2-Acetylamino-4-chlormethyl-5-chlor-thiazol | 16444-04-5

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 2-Acetylamino-4-chlormethyl-5-chlor-thiazol
• 英文别名: 2-acetamido-5-chloro-4-chloromethylthiazole；N-(5-chloro-4-chloromethyl-thiazol-2-yl)-acetamide；N-[5-chloro-4-(chloromethyl)-1,3-thiazol-2-yl]acetamide
• CAS: 16444-04-5
• 化学式: C₆H₆Cl₂N₂OS
• 分子量: 225.098
• InChiKey: QRZHEARLFCGCRX-UHFFFAOYSA-N

物化性质

• 密度：
  1.553±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  70.2
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-Acetylamino-4-chlormethyl-5-chlor-thiazol 在 sodium hydride 、 sodium iodide 作用下， 以 N,N-二甲基甲酰胺 、 丙酮 为溶剂， 反应 2.0h， 生成 5-{(2-acetamido-5-chlorothiazol-4-yl)methoxy}isoquinoline
  参考文献：
  名称：

  Studies on Anti-Helicobacter pylori Agents. Part 1: Benzyloxyisoquinoline Derivatives

  摘要：

  The synthesis and optimization of the anti-Helicobacter pylori activity of a novel series of benzyloxyisoquinoline derivatives that was discovered by a random screening process, are described. In the in vitro assay, compound 10c containing a 3-acetamido-2,6-dichlorobenzyl substituent was found to have extremely potent activity against H. pylori and no activity against other common bacteria. The anti-H. pylori activity of 10c was superior to that of amoxicillin (AMPC) (1) and clarithromycin (CAM) (2), However, 10c did not show in vivo efficacy in a mouse infection model; a feature attributed to the lack of strong bactericidal activity at short contact times. (C) 1999 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(99)00203-5
• 作为产物：
  描述：

  2 -乙酰氨基- 4-(氯甲基)-1,3-噻唑 在 氯化亚砜 作用下， 生成 2-Acetylamino-4-chlormethyl-5-chlor-thiazol
  参考文献：
  名称：

  Silberg,A.; Frenkel,Z., Bulletin de la Societe Chimique de France, 1967, p. 2235 - 2238

  摘要：

  DOI：

文献信息

• Benzhydrylpiperozinyl thiazole derivatives and pharmaceutical
  申请人：Fujisawa Pharmaceutical Co., Ltd.

  公开号：US04411900A1

  公开（公告）日：1983-10-25

  Benzhydrylpiperazinyl Thiazole compounds of the formula ##STR1## wherein R.sup.1 is hydrogen, amino, or mono- or di- substituted amino, in which the substituent is selected from lower alkyl, acyl and di(lower)alkylaminomethylene, R.sup.2 is hydrogen, halogen, lower alkyl or aryl, R.sup.3 is ar(lower)alkyl optionally substituted by halogen, A is lower alkylene optionally interrupted by a sulfur atom, and Y is C.sub.1 -C.sub.3 alkylene, having antiallergic activity.

  Benzhydrylpiperazinyl噻唑化合物的化学式为##STR1##其中R.sup.1为氢，氨基，或者单取代或双取代氨基，取代基选自较低的烷基，酰基和二(较低)烷基氨基甲烯，R.sup.2为氢，卤素，较低的烷基或芳基，R.sup.3为可选择地被卤素取代的芳基(较低)烷基，A为可选择地由硫原子中断的较低烷基，Y为C.sub.1 -C.sub.3烷基，具有抗过敏活性。
• Thiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
  申请人：FUJISAWA PHARMACEUTICAL CO., LTD.

  公开号：EP0032058A1

  公开（公告）日：1981-07-15

  The thiazole derivatives have the general formula:- wherein R1 is hydrogen, amino, or mono-or di-substituted amino, in which the substituent is selected from lower alkyl, acyl and di (lower) alkylaminomethylene, R2 is hydrogen, halogen, lower alkyl or aryl, R3 is ar(lower)alkyl optionally substituted by halogen, A is lower alkylene optionally interrupted by a sulfur atom, and Y is C1-C3 alkylene, and their pharmaceutically - acceptable salts, are useful as antiallergic agents.

  噻唑衍生物的通式如下 其中 R1 是氢、氨基或单或二取代氨基，其中取代基选自低级烷基、酰基和二（低级）烷基氨基亚甲基、 R2 是氢、卤素、低级烷基或芳基、 R3 是可选被卤素取代的 ar（低级）烷基、 A 是可选被硫原子打断的低级亚烷基，以及 Y 是 C1-C3 亚烷基，以及它们的药学上可接受的 盐可用作抗过敏剂。
• Silberg,A.; Frenkel,Z., Bulletin de la Societe Chimique de France, 1967, p. 2235 - 2238
  作者：Silberg,A.、Frenkel,Z.

  DOI：——

  日期：——
• US4411900A
  申请人：——

  公开号：US4411900A

  公开（公告）日：1983-10-25
• Studies on Anti-Helicobacter pylori Agents. Part 1: Benzyloxyisoquinoline Derivatives
  作者：Yoshiki Yoshida、David Barrett、Hidenori Azami、Chizu Morinaga、Satoru Matsumoto、Yoshimi Matsumoto、Hisashi Takasugi

  DOI：10.1016/s0968-0896(99)00203-5

  日期：1999.11

  The synthesis and optimization of the anti-Helicobacter pylori activity of a novel series of benzyloxyisoquinoline derivatives that was discovered by a random screening process, are described. In the in vitro assay, compound 10c containing a 3-acetamido-2,6-dichlorobenzyl substituent was found to have extremely potent activity against H. pylori and no activity against other common bacteria. The anti-H. pylori activity of 10c was superior to that of amoxicillin (AMPC) (1) and clarithromycin (CAM) (2), However, 10c did not show in vivo efficacy in a mouse infection model; a feature attributed to the lack of strong bactericidal activity at short contact times. (C) 1999 Elsevier Science Ltd. All rights reserved.